Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective (Q46242175)
Jump to navigation
Jump to search
scientific article published on 28 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective |
scientific article published on 28 July 2011 |
Statements
1 reference
Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective (English)
1 reference
Ron Akehurst
1 reference
Haesuk Park
1 reference
Karen L Rascati
1 reference
Michael S Keith
1 reference
Paul Hodgkins
1 reference
Michael Smyth
1 reference
David Goldsmith
1 reference
28 July 2011
1 reference
1 reference
14
1 reference
8
1 reference
1002-1009
1 reference
Identifiers
1 reference